Clinical Trials Directory

Trials / Completed

CompletedNCT05502328

Radicle Energy: A Study of Cannabinoids on Energy and Other Health Outcomes

Radicle™ Energy: A Randomized, Blinded, Placebo-controlled Study of Cannabinoid Formulations and Their Effects on Energy Levels, Focus, Appetite and Other Health Outcomes

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
1,427 (actual)
Sponsor
Radicle Science · Industry
Sex
All
Age
21 Years – 105 Years
Healthy volunteers
Accepted

Summary

A randomized, blinded, placebo-controlled study of cannabinoid formulations and their effects on energy levels, focus, appetite and other health outcomes

Detailed description

This is a randomized, blinded, placebo-controlled study conducted with up to 300 adult participants per study arm (3000 total), age 21 and older and residing in the United States. Eligible participants will (1) endorse a desire for more energy (less fatigue and/or better concentration/focus during screening); (2) indicate a willingness to refrain from taking cannabinoids during the study period, and (3) indicate an interest in taking a plant derived cannabinoid product to help with their energy and/or focus. Participants with known liver disease, heavy drinkers, and those who are pregnant, trying to become pregnant, or breastfeeding will be excluded. Those taking medications that warn against grapefruit consumption will be excluded. People with a calculated BMI of 18.5 or less will be excluded. Self-reported data are collected electronically from eligible participants over 5 weeks. Participant reports of health indicators will be collected during baseline, throughout the active period of study product use, and in a final survey. All study assessments will be electronic; there are no in-person visits or assessments for this real-world evidence study.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTEnergy Study Product UsageParticipants will use their Radicle Energy study product as directed for a period of 4 weeks.

Timeline

Start date
2022-08-17
Primary completion
2022-12-31
Completion
2023-05-24
First posted
2022-08-16
Last updated
2023-11-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05502328. Inclusion in this directory is not an endorsement.